Valuation: DNA X, Inc.

Market Cap 5.13M 4.49M 4.15M 3.81M 7.21M 495M 7.33M 49.5M 19.44M 242M 19.28M 18.86M 834M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 8.9M 7.78M 7.19M 6.6M 12.49M 857M 12.71M 85.77M 33.69M 419M 33.41M 32.68M 1.45B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
63.9%
Yield 2024 *
-
Yield 2025 -
1 day-6.50%
1 week-14.39%
Current month-33.01%
1 month-27.22%
3 months+8.49%
6 months-26.60%
Current year+9.52%
1 week 3.38
Extreme 3.3824
4.43
1 month 3.18
Extreme 3.1801
6.14
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
16.97
3 years 2.52
Extreme 2.5211
199.1
5 years 2.52
Extreme 2.5211
1,322.28
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 2026-02-08
Director of Finance/CFO 64 2022-07-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 2023-11-12
Director/Board Member 64 2022-07-12
Director/Board Member 79 2022-07-12
Date Insider Type Main position Quantity % Market Cap.
2/9/26 Free

Chief Financial Officer

35,000 2.3514%
2/9/26 Free

Chief Executive Officer

50,000 3.3592%
7/18/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-6.50%-14.39%-73.68%-98.30% 5.13M
-8.77%-8.27%+294.13%+247.41% 1,087B
+2.05%+10.50%-22.31%+23.15% 1.73B
-2.09%-0.52%+16.63%+305.97% 1.2B
-2.14%-3.99%+4.46%-26.28% 1.12B
-2.56%-3.73%+63.73%+47.69% 1.05B
-5.02%-0.39%-11.63%+69.40% 598M
-1.00%+6.67%-7.67%+150.76% 536M
+2.07%-1.25%+16.52%-8.14% 437M
0.00%-7.48%-19.44%+281.38% 177M
Average -2.40%-5.21%+26.07%+99.31% 109.39B
Weighted average by Cap. -8.72%-10.47%+292.33%+246.41%

Financials

2024 2025
Net sales 58.3M 50.96M 47.13M 43.24M 81.85M 5.62B 83.27M 562M 221M 2.74B 219M 214M 9.47B -
Net income -33.65M -29.41M -27.2M -24.96M -47.24M -3.24B -48.06M -324M -127M -1.58B -126M -124M -5.47B -20.66M -18.06M -16.7M -15.32M -29M -1.99B -29.5M -199M -78.23M -972M -77.58M -75.87M -3.36B
Net Debt -5.34M -4.67M -4.32M -3.96M -7.5M -515M -7.63M -51.51M -20.23M -251M -20.07M -19.62M -868M 3.76M 3.29M 3.04M 2.79M 5.28M 363M 5.37M 36.27M 14.25M 177M 14.13M 13.82M 611M
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
26-07-16 US$3.450 -6.50% 23,076
26-07-15 US$3.690 -14.78% 64,746
26-07-14 US$4.330 -0.23% 45,625
26-07-13 US$4.340 +7.16% 18,088
26-07-10 US$4.050 +0.50% 12,201

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SONM Stock